NPC2 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

333 results for “NPC2”

Trials

View all 272 →

Biomarker for Niemann Pick Type C Disease (BioNPC)

First posted Mar 2, 2011

Not yet recruiting

Pembrolizumab + MRGOO3 as Neoadjuvant in NPC

35 participants · First posted Dec 5, 2025

Active, not recruiting

NEO-SPACE Trial: Pembrolizumab and Chemoradiation in Nasopharyngeal Cancer

43 participants · First posted Nov 8, 2018

Drugs

View all 49 →

NPC-22009

NPC-17923

NPC-349

News

View all 12 →

Beren Therapeutics and GeneDx Launch 'Test for NPC' to Accelerate Diagnosis of Niemann-Pick Disease Type C

FDA Advisory Committee Supports Arimoclomol for Niemann-Pick Disease Type C

Azafaros' Nizubaglustat Gains Orphan Drug Designations, Phase 3 Trials to Start in 2025

Page 1 of 34